Cigna Corp vs Global X Robo Global Robotics & Automation ETF — how do they compare? Cigna Corp trades at $299.91 (market cap $80.25B), while Global X Robo Global Robotics & Automation ETF trades at $81.33. The key difference: Cigna Corp pays a 2.06% dividend while Global X Robo Global Robotics & Automation ETF pays none, and Cigna Corp is trading nearer its 52-week high, Global X Robo Global Robotics & Automation ETF nearer its low. Which is the better fit depends on your goals.
| CI | ROBO | |
|---|---|---|
Market Cap | $80.25B | — |
Sector | Health | Sector/Thematic |
52-Week High | $311.00 | $90.34 |
52-Week Low | $244.41 | $60.15 |
Enterprise Value | $103.35B | — |
Dividend Yield | 2.06% | — |
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.
The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.
ROBO, the ROBO Global Robotics and Automation Index ETF, trades at $80.56, down 2.89% over 24 hours amid a bearish technical signal. Key support lies at $79, with resistance at $82. Recent news highlights its diversified AI-driven portfolio and a rebalance toward AI infrastructure, though valuation metrics are not provided in the snapshot. The ETF's performance reflects sector-specific momentum and exposure to cyclical markets like automotive.
Outlook remains mixed; the ETF offers growth exposure to robotics and AI themes, but bearish technical indicators and cyclical risks warrant caution. Investment appeal hinges on sustained AI adoption, while risks include market volatility and competitive pressures in the technology sector.
Trailing returns across standard periods
Latest headlines on both assets
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →